title: Visceral larva migrans and alveolar hydatid disease. Dangers real or imagined.
abstract: For both visceral larva migrans and alveolar hydatid diseases, it is the feces of companion animals that are the primary source of human infection. Clearly, whatever is done to reduce this form of environmental contamination and the prevalence of the parasites' infective stages will help to protect the health of the human population in the United States and Canada, particularly the children. Very important are appropriate anthelmintic treatment programs, especially for T. canis, and proper control of close associations between pets and people. Probably the known incidence of visceral larva migrans in humans and the range of its known pathogenicity will increase as better diagnostic methods become available. In addition, other animal helminths, for instance Toxocara cati and Toxascaris leonina, may become more substantially documented as causes of human visceral larva migrans. Until more is known of the geographical distribution and prevalence of Echinococcus multilocularis among animals in North America, it will be difficult to assess accurately the future significance of alveolar hydatid disease in the continent's human population. Another important advance would be the development of anthelmintics that are effective for somatic second stage larvae of T. canis, and others effective for adult or larval Echinococcus species. Meanwhile it is a most important responsibility of the veterinary profession to educate its clients thoroughly concerning these dangerous helminths.
mesh_terms: D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use; D001196:Ascariasis / Q000662:veterinary*; D001927:Brain Diseases / Q000469:parasitology; D002170:Canada; D002371:Cat Diseases / Q000188:drug therapy / Q000469:parasitology / Q000635:transmission; D002415:Cats; D002648:Child; D004283:Dog Diseases / Q000188:drug therapy / Q000469:parasitology / Q000635:transmission; D004285:Dogs; D004445:Echinococcosis, Pulmonary / Q000188:drug therapy / Q000453:epidemiology / Q000662:veterinary*; D004446:Echinococcus / Q000254:growth & development; D005128:Eye Diseases / Q000469:parasitology; D005260:Female; D005843:Geography; D006801:Humans; D007816:Larva Migrans, Visceral / Q000188:drug therapy / Q000469:parasitology / Q000635:transmission*; D008297:Male; D008875:Middle Aged; D014119:Toxocara / Q000254:growth & development; D014120:Toxocariasis / Q000188:drug therapy / Q000453:epidemiology / Q000469:parasitology / Q000635:transmission / Q000662:veterinary*; D014481:United States
chemical_list: D000871:Anthelmintics